JMN Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
JMN Financial's BIIB Position: Q3 2026 in Review
JMN Financial reduced its Biogen (BIIB) stake by 14% in Q3 2026, selling an estimated $41.8K and leaving 1,214 shares worth $274K. The position accounts for 0.22% of the portfolio, ranked #134.
JMN Financial first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. The position peaked at $305K in Q2 2026. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- JMN Financial held 1,214 shares of Biogen worth $274K as of Q3 2026.
- JMN Financial sold 197 Biogen shares in Q3 2026, an estimated $41.8K.
- Biogen made up 0.22% of JMN Financial's portfolio in Q3 2026, its #134 holding.
- JMN Financial first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
- JMN Financial's Biogen position peaked at $305K in Q2 2026.
- 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on JMN Financial's 13F filing for Q3 2026, filed 10 Nov 2026.